Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
01/2011
01/06/2011US20110003994 Cycloalkane derivative
01/06/2011US20110003853 Metalloproteinase Inhibitors
01/06/2011US20110003838 Whitening Agent And Skin External Preparation
01/06/2011US20110003836 Pro-Neurogenic Compounds
01/06/2011US20110003827 HIV protease inhibiting compounds
01/06/2011US20110003825 Substituted amide beta secretase inhibitors
01/06/2011US20110003823 Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage
01/06/2011US20110003818 Substituted 2-Carboxamide Cycloamino Ureas
01/06/2011US20110003817 Whitening Agent And Skin External Preparation
01/06/2011US20110003815 Diphenyl substituted cycloalkanes
01/06/2011US20110003814 Pyrimidines useful as modulators of voltage-gated ion channels
01/06/2011US20110003812 Human Adam-10 Inhibitors
01/06/2011US20110003799 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
01/06/2011US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
01/06/2011US20110003794 Naphthyridine Integrase Inhibitors
01/06/2011US20110003787 Novel phenylpyrrole derivative
01/06/2011US20110003759 Non-basic melanin concentrating hormone receptor-1 antagonists and methods
01/06/2011US20110003691 Substituted Pyrazinylmethyl Sulfonamides For Use As Fungicides
01/06/2011US20110003690 Insecticidal arylpyrrolines
01/06/2011US20110003362 Conjugates of biological substances
01/06/2011US20110003316 Luminescence-based methods and probes for measuring cytochrome p450 activity
01/06/2011US20110002855 Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues
01/06/2011US20110002850 Nitro-Imidazole Hypoxia Imaging Agent
01/06/2011US20110001129 Substituted bipyridyl compound and organic electroluminescent device
01/06/2011CA2767097A1 Pyrazolopyrimidine jak inhibitor compounds and methods
01/06/2011CA2767064A1 Novel (6-oxo-1, 6-dihydro-pyrimidin-2-yl)-amide derivatives, preparation thereof, and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
01/06/2011CA2766162A1 Smac mimetic
01/06/2011CA2764425A1 Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
01/05/2011EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands
01/05/2011EP2270001A1 Indolylmaleimide derivatives as PKC inhibitors
01/05/2011EP2269993A1 2-aminoquinazoline derivative
01/05/2011EP2269610A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
01/05/2011EP2268635A1 Heterocyclic compounds
01/05/2011EP2268634A2 Processes for the preparation of bosentan and related compounds using novel intermediates
01/05/2011EP2268633A1 Pyridazinone glucokinase activators
01/05/2011EP2268624A1 Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
01/05/2011EP2268615A1 Pesticides
01/05/2011EP1881977B1 Histone deacetylase inhibitors
01/05/2011EP1633726B1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
01/05/2011EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain
01/05/2011CN101939316A Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
01/05/2011CN101939315A Gamma secretase modulators
01/05/2011CN101939314A Polymorphic forms of a 3-pyrrole substituted 2-indolinone
01/05/2011CN101939312A Gamma secretase modulators
01/05/2011CN101939295A Insecticidal arylpyrrolines
01/05/2011CN101939054A Organic compounds
01/05/2011CN101939053A Soluble guanylate cyclase activators
01/05/2011CN101933926A Indolylmaleimde derivatives as PKC inhibitors
01/05/2011CN101260246B Conjugated cation dyestuff and preparation method thereof
01/05/2011CN101250185B Pyrrone nidazole ester compound as well as preparation method and use thereof
01/04/2011US7863478 UV filters
01/04/2011US7863455 Electrochemically active ligand for sequence-specific detection of double-stranded nucleic acid molecule
01/04/2011US7863451 preparation of 3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; for preventing or treating diseases or conditions related to an abnormally high level or activity of TNF
01/04/2011US7863446 Heterocycles
01/04/2011US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
01/04/2011US7863314 Pyrazole and/or imidazole based compounds; inflammatory diseases and disorders; synthesis
01/04/2011US7863310 Kinase inhibitors
01/04/2011US7863299 Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine D3 receptor modulators
01/04/2011US7863292 modulators of hypoxia inducible factors and/or endogenous erythropoietin, such as 1-Chloro-4-hydroxy-7-isopropoxy-isoquinoline-3-carboxylic acid (2-hydroxy-1-hydroxymethyl-ethyl)-amide, used for the treatment of anemic disorders, neurological disorders and/or injuries
01/04/2011US7863284 such as N-{N-{4-[N-(2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclo-penta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamic acid, used for aiding regression and palliation of ovarian cancer; antiproliferative agents
01/04/2011US7863282 Pyrimidylamino- or triazinylamino- substituted pyrazoles or 1,2,3-triazoles
01/04/2011CA2577667C 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase ie
01/04/2011CA2487424C Copper-catalysed ligation of azides and acetylenes
01/04/2011CA2465207C Pyrazole-amides and -sulfonamides
01/04/2011CA2458533C Imidazole derivates as anti-inflammatory agents
01/04/2011CA2451238C Cyclic diamine compound with 5 membered ring groups
01/04/2011CA2425531C Process for producing substituted aniline compounds from acetanilides
01/04/2011CA2413426C Methods and compositions utilizing quinazolinones
01/04/2011CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/2010
12/30/2010US20100331543 Cyanine dyes and their applications as luminescence quenching compounds
12/30/2010US20100331509 Carbazole-based hole transport and/or electron blocking materials and/or host polymer materials
12/30/2010US20100331384 Guanidine based compounds
12/30/2010US20100331352 Novel crystalline forms of bosentan
12/30/2010US20100331346 Beta-amino acid derivatives for treatment of diabetes
12/30/2010US20100331342 Immuno Inhibitory Pyrazolone Compounds
12/30/2010US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors
12/30/2010US20100331327 7-substituted indirubin-3'oximes and their applications
12/30/2010US20100331324 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function
12/30/2010US20100331315 Rhodanines and related heterocycles as kinase inhibitors
12/30/2010US20100331312 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
12/30/2010US20100331309 Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
12/30/2010US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
12/30/2010US20100331300 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/30/2010US20100331299 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/30/2010US20100331298 Carboxamide Compounds and Their Use
12/30/2010US20100331295 Modulators of lxr
12/30/2010US20100331294 4-substituted-2-amino-pyrimidine derivatives
12/30/2010US20100330681 SELECTIVE DETECTION OF Hg2+ BY CALIX[4]ARENES
12/30/2010US20100330130 Substantially pure imatinib or a pharmaceutically acceptable salt thereof
12/30/2010US20100330077 1-acetic acid-indole derivatives with pgd2 antagonist activity
12/30/2010US20100330069 Heterocyclic compounds and methods of use
12/30/2010US20100330030 Vasculostatic Agents and Methods of Use Thereof
12/30/2010US20100329998 Novel heterocycles
12/30/2010US20100329978 Highly selective sigma receptor ligands
12/30/2010US20100326526 Emissive aryl-heteroaryl compounds
12/29/2010WO2010151672A2 Amino acid derived ureas
12/29/2010WO2010149755A1 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
12/29/2010WO2010149685A1 New compounds, pharmaceutical composition and methods relating thereto
12/29/2010WO2010149506A1 Insecticidal compounds
12/29/2010WO2010149326A1 Acid-labile trigger units